PPP1R2P3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.149400E-01
Normal-vs-Stage2
3.028000E-01
Normal-vs-Stage3
1.397800E-01
Normal-vs-Stage4
7.443800E-01
Stage1-vs-Stage2
7.101600E-01
Stage1-vs-Stage3
2.941600E-01
Stage1-vs-Stage4
3.815000E-01
Stage2-vs-Stage3
2.644000E-01
Stage2-vs-Stage4
3.418600E-01
Stage3-vs-Stage4
1.424040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.938400E-01
Normal-vs-AfricanAmerican
9.956600E-01
Normal-vs-Asian
1.691000E-01
Caucasian-vs-AfricanAmerican
4.219600E-01
Caucasian-vs-Asian
2.775400E-01
AfricanAmerican-vs-Asian
1.560210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.927200E-01
Normal-vs-Female
3.995200E-01
Male-vs-Female
2.383600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.169200E-01
Normal-vs-Age(41-60Yrs)
7.129600E-01
Normal-vs-Age(61-80Yrs)
2.167400E-01
Normal-vs-Age(81-100Yrs)
1.341950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.058800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.282000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.566000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.143200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.223800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.942600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.620500E-02
Normal-vs-Daily Drinker
2.358000E-02
Normal-vs-Weekly Drinker
1.649180E-01
Normal-vs-Occasional Drinker
7.890000E-01
Normal-vs-Social Drinker
4.953200E-01
Non Drinker-vs-Daily Drinker
3.897800E-01
Non Drinker-vs-Weekly Drinker
9.795800E-01
Non Drinker-vs-Occasional Drinker
4.775900E-02
Non Drinker-vs-Social Drinker
1.334950E-01
Daily Drinker-vs-Weekly Drinker
5.400200E-01
Daily Drinker-vs-Occasional Drinker
1.911750E-02
Daily Drinker-vs-Social Drinker
3.310000E-02
Weekly Drinker-vs-Occasional Drinker
1.085770E-01
Weekly Drinker-vs-Social Drinker
2.326000E-01
Occasional Drinker-vs-Social Drinker
5.682200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.201440E-01
Normal-vs-Grade 2
4.324000E-03
Normal-vs-Grade 3
2.197800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.834630E-01
Grade 1-vs-Grade 3
2.469400E-01
Grade 1-vs-Grade 4
1.201440E-01
Grade 2-vs-Grade 3
8.748800E-01
Grade 2-vs-Grade 4
4.324000E-03
Grade 3-vs-Grade 4
2.197800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.418750E-01
Normal-vs-NonDiabetic
2.189600E-01
Diabetic-vs-NonDiabetic
5.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.502800E-01
Normal-vs-NoPancreatitis
2.115400E-01
Pancreatitis-vs-NoPancreatitis
6.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.429200E-01
Normal-vs-N1
3.042600E-01
N0-vs-N1
9.768600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.444800E-01
Normal-vs-TP53-NonMutant
3.880000E-01
TP53-Mutant-vs-TP53-NonMutant
1.302430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
